Techne Corp (NASDAQ:TECH)
CAPS Rating:
The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.
The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Sales have grown steadily while the cost of sales has decreased. Revenue and earnings have also increased over the past two years.